100 related articles for article (PubMed ID: 31580432)
1. Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
Schneeweiss S; Carver PL; Datta K; Galar A; Johnson MD; Letourneau AR; Marty FM; Nagel J; Najdzinowicz M; Saul M; Schuster M; Shoham S; Silveira FP; Varughese C; Wilck M; Weatherby L; Oene JV; Walker AM
J Antimicrob Chemother; 2020 Jan; 75(1):221-228. PubMed ID: 31580432
[TBL] [Abstract][Full Text] [Related]
2. Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study.
Schneeweiss S; Carver PL; Datta K; Galar A; Johnson MD; Johnson MG; Marty FM; Nagel J; Najdzinowicz M; Saul M; Shoham S; Silveira FP; Varughese CA; Wilck M; Weatherby L; Auton T; Walker AM
J Antimicrob Chemother; 2016 Oct; 71(10):2938-44. PubMed ID: 27407049
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment of micafungin-induced liver injury using spontaneous reporting system data and electronic medical records.
Asai Y; Yamamoto T; Sato Y
J Infect Chemother; 2022 May; 28(5):690-695. PubMed ID: 35148944
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
5. Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.
Choi J; Kim HJ; Lee J; Cho S; Ko MJ; Lim YS
JAMA Oncol; 2019 Jan; 5(1):30-36. PubMed ID: 30267080
[TBL] [Abstract][Full Text] [Related]
6. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
Rich N; Tanriover B; Singal AG; Marrero JA
Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
[TBL] [Abstract][Full Text] [Related]
8. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis.
Hsu CY; Liu PH; Lee YH; Hsia CY; Huang YH; Chiou YY; Tsai YJ; Nagaria TS; Huo TI
Ann Surg Oncol; 2015 Apr; 22(4):1324-31. PubMed ID: 25326394
[TBL] [Abstract][Full Text] [Related]
9. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
10. Short- and long-term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK.
Wallace D; Cowling TE; Walker K; Suddle A; Rowe I; Callaghan C; Gimson A; Bernal W; Heaton N; van der Meulen J
Br J Surg; 2020 Jun; 107(7):896-905. PubMed ID: 32128793
[TBL] [Abstract][Full Text] [Related]
11. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Makarova-Rusher OV; Altekruse SF; McNeel TS; Ulahannan S; Duffy AG; Graubard BI; Greten TF; McGlynn KA
Cancer; 2016 Jun; 122(11):1757-65. PubMed ID: 26998818
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
Lin H; Li X; Liu Y; Hu Y
ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis.
Lee SW; Kwon JH; Lee HL; Yoo SH; Nam HC; Sung PS; Nam SW; Bae SH; Choi JY; Yoon SK; Han NI; Jang JW
Gut; 2020 Jul; 69(7):1301-1308. PubMed ID: 31672838
[TBL] [Abstract][Full Text] [Related]
14. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
15. Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.
Andreou A; Struecker B; Raschzok N; Krenzien F; Haber P; Wabitsch S; Waldbaur C; Touet EM; Eichelberg AC; Atanasov G; Biebl M; Bahra M; Öllinger R; Schmelzle M; Pratschke J
Surg Oncol; 2018 Dec; 27(4):751-758. PubMed ID: 30449503
[TBL] [Abstract][Full Text] [Related]
16. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
[TBL] [Abstract][Full Text] [Related]
17. Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis.
Otu AA; Bongomin F; Bazaz R; Harris C; Denning DW; Kosmidis C
Mycoses; 2019 Feb; 62(2):152-156. PubMed ID: 30267594
[TBL] [Abstract][Full Text] [Related]
18. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
[TBL] [Abstract][Full Text] [Related]
19. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis.
Su CW; Lei HJ; Chau GY; Hung HH; Wu JC; Hsia CY; Lui WY; Su YH; Wu CW; Lee SD
Arch Surg; 2012 Feb; 147(2):137-44. PubMed ID: 22006855
[TBL] [Abstract][Full Text] [Related]
20. Refractory neonatal candidemia and high-dose micafungin pharmacotherapy.
Natarajan G; Lulic-Botica M; Aranda JV
J Perinatol; 2009 Nov; 29(11):738-43. PubMed ID: 19776753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
